NCT02673593View on ClinicalTrials.gov

Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

DRUG

DS102

DRUG

Placebo

Trial Locations (1)

Unknown

DS Biopharma Investigational Site, Belfast

Sponsors

Lead Sponsor

All Listed Sponsors

lead

DS Biopharma

INDUSTRY